KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2025)

Royalty Pharma's FCF Payout Ratio history spans 6 years, with the latest figure at 0.44 for Q4 2025.

  • For Q4 2025, FCF Payout Ratio rose 241.26% year-over-year to 0.44; the TTM value through Dec 2025 reached 0.2, down 58.44%, while the annual FY2025 figure was 0.21, 55.52% down from the prior year.
  • FCF Payout Ratio for Q4 2025 was 0.44 at Royalty Pharma, up from 50.93 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 5.46 in Q1 2021 and bottomed at 406.06 in Q1 2022.
  • The 5-year median for FCF Payout Ratio is 0.0 (2024), against an average of 28.34.
  • The largest annual shift saw FCF Payout Ratio skyrocketed 1157.68% in 2021 before it crashed 92148.83% in 2025.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.72 in 2021, then soared by 114.34% to 0.1 in 2022, then tumbled by 46.21% to 0.06 in 2023, then surged by 129.11% to 0.13 in 2024, then skyrocketed by 241.26% to 0.44 in 2025.
  • Per Business Quant, the three most recent readings for RPRX's FCF Payout Ratio are 0.44 (Q4 2025), 50.93 (Q1 2025), and 0.13 (Q4 2024).